Temporal Changes in SGLT2 Inhibitor and GLP-1 Receptor Agonist Use in Patients with Chronic Kidney Disease and Type 2 Diabetes, 2012-2023: A US Cohort Study.
Saved in:
| Title: | Temporal Changes in SGLT2 Inhibitor and GLP-1 Receptor Agonist Use in Patients with Chronic Kidney Disease and Type 2 Diabetes, 2012-2023: A US Cohort Study. |
|---|---|
| Authors: | Johannes CB; RTI Health Solutions, Waltham, MA, USA., Coleman CI; University of Connecticut School of Pharmacy, Storrs, CT, USA.; Evidence-Based Practice Center, Hartford Hospital, Hartford, CT, USA., Kovesdy CP; Division of Nephrology, Department of Medicine, University of Tennessee Health Science Center, Memphis, TN, USA., Khan AM; RTI Health Solutions, Waltham, MA, USA. amkhan@rti.org., Ziemiecki R; RTI Health Solutions, Durham, NC, USA., Layton JB; RTI Health Solutions, Durham, NC, USA., Vizcaya D; Bayer AG, Berlin, Germany., Liu F; Bayer AG, Berlin, Germany., Oberprieler NG; Bayer AG, Berlin, Germany. |
| Source: | Diabetes therapy : research, treatment and education of diabetes and related disorders [Diabetes Ther] 2026 Feb; Vol. 17 (2), pp. 231-250. Date of Electronic Publication: 2025 Dec 09. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Healthcare Country of Publication: United States NLM ID: 101539025 Publication Model: Print-Electronic Cited Medium: Print ISSN: 1869-6953 (Print) Linking ISSN: 18696961 NLM ISO Abbreviation: Diabetes Ther Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1869-6953 |
|---|---|
| DOI: | 10.1007/s13300-025-01825-5 |
